The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading ->
The World Health Organization (WHO) has given its quality seal of approval to a biologically similar formulation of the breast cancer drug  – trastuzumab – in a move the agency says could help make the costly, life-saving treatment more affordable and available to women globally. Breast cancer is the most common form of cancer in […] Continue reading ->
Make the ¨healthiest choices the easiest choices¨ to prevent many non-communicable diseases. This was a key message from an Independent High-Level Commission report on Non-communicable diseases (NCDs), released Tuesday at a WHO Global Meeting to Accelerate Progress NCDs and Mental Health in Muscat, Oman. The report, ¨It´s Time to Walk the Talk¨, released on the […] Continue reading ->
The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading ->